Trop-2 is overexpressed in all breast cancer subtypes, however it is most elevated in triple negative breast cancer (TNBC) as compared to estrogen receptor positive (ER+) or HER-2+ tumors [2,16]. This evidence concerns the gene TACSTD2 and triple-negative breast carcinoma.